The matrix metalloproteinases and their inhibitors in pancreatic cancer Simon R. Bramhall State-of-the-Art Pages: 1 - 12
A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis Colin McKayJohn BaxterClem Imrie Original Articles Pages: 13 - 19
Modification of blood group a expression in human pancreatic tumor cell lines by inhibitors ofN-glycan processing Courtney SchaffertParviz M. PourWilliam G. Chaney Original Articles Pages: 21 - 29
Results of adjuvant therapy in resected pancreatic cancer Åke Andrén-SandbergPia Lena BäckmanRoland Andersson Original Articles Pages: 31 - 38
Chemotherapy in advanced pancreatic cancer Wolfgang DippoldHelga BernhardKarl-Hermann Meyer zum Büschenfelde Original Articles Pages: 39 - 41
Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers Helmut FriessMichael GassmannMarkus W. Büchler Original Articles Pages: 43 - 52
Intraoperative and postoperative radiotherapy in pancreatic cancer Valerio Di CarloAlessandro ZerbiEugenio Villa Original Articles Pages: 53 - 58
Adjuvant chemotherapy in pancreatic cancer Simon R. BramhallJohn P. Neoptolemos Original Articles Pages: 59 - 63
Celiac artery adjuvant chemotherapy Karl-Heinrich LinkFrank GansaugeHans-Günther Beger Original Articles Pages: 65 - 69
Multimodal therapies in ductal pancreatic cancer Karl-Heinrich LinkFrank GansaugeHans-Günther Beger Original Articles Pages: 71 - 83
Sclerosing pancreatitis showing rapidly progressive changes with recurrent mass formation Yoshiharu MotooToshinari MinamotoNorio Sawabu Case Report Pages: 85 - 90
Unusual presentation of a pancreatic pseudocyst Robert MunkelwitzSvetlana KrasnokutskyS. Ali Khan Case Report Pages: 91 - 94